Literature DB >> 2670634

Efficacy and tolerability of nimesulide in elderly patients with osteoarthritis: double-blind trial versus naproxen.

V Fossaluzza1, G Montagnani.   

Abstract

A double-blind trial was carried out to assess the therapeutic efficacy and tolerability of nimesulide versus naproxen in the treatment of elderly patients with osteoarthritis. A total of 40 elderly female patients with osteoarthritis of the hip and/or knee were entered into the study and treated with either 200 mg/day nimesulide or 500 mg/day naproxen for 28 days. Both treatments were very effective in alleviating spontaneous pain, pain on movement, morning stiffness and joint mobility. Nimesulide was better tolerated than naproxen with fewer and less serious side-effects being reported. The results of this study show nimesulide to be effective and well tolerated in the treatment of elderly patients with osteoarthritis.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2670634     DOI: 10.1177/030006058901700313

Source DB:  PubMed          Journal:  J Int Med Res        ISSN: 0300-0605            Impact factor:   1.671


  5 in total

Review 1.  Non-steroidal anti-inflammatory drugs (NSAIDs) and gastro-intestinal toxicity: current issues.

Authors:  A A Shah; D J Fitzgerald; F E Murray
Journal:  Ir J Med Sci       Date:  1999 Oct-Dec       Impact factor: 1.568

Review 2.  Naproxen. A reappraisal of its pharmacology, and therapeutic use in rheumatic diseases and pain states.

Authors:  P A Todd; S P Clissold
Journal:  Drugs       Date:  1990-07       Impact factor: 9.546

3.  A Double-Blind Study Comparing Nimesulide with Naproxen in the Treatment of Osteoarthritis of the Hip.

Authors:  M Quattrini; S Paladin
Journal:  Clin Drug Investig       Date:  1995-09       Impact factor: 2.859

Review 4.  Nimesulide. An update of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy.

Authors:  R Davis; R N Brogden
Journal:  Drugs       Date:  1994-09       Impact factor: 9.546

5.  Efficacy and safety of a fixed-dose combination of nimesulide/pantoprazole compared to naproxen/esomeprazole for pain relief in patients with osteoarticular diseases and dyspeptic symptoms.

Authors:  Morton Scheinberg; Henrique Pott Júnior; Eduardo de Almeida Macêdo; Monalisa Fernanda Bocchi de Oliveira; Christina Ecclissato; Roberto Bleuel Amazonas
Journal:  Drug Des Devel Ther       Date:  2018-09-06       Impact factor: 4.162

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.